Reliability, Criterion and Concurrent Validity of the Farsi Translation of DIVA-5: A Semi-Structured Diagnostic Interview for Adults With ADHD

Zamani, Lida; Shahrivar, Zahra; Alaghband-Rad, Javad; Sharifi, Vandad; Davoodi, Elham; Ansari, Shadi; Emari, Fatemeh; Wynchank, Dora; Kooij, J. J. Sandra; Asherson, Philip

doi:10.1177/1087054720930816

Cited by 12 publications

(7 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They also stated that general ADHD factor explained 81.0% of the SCID-5 ADHD criteria reliable score variance [ 41 ]. Also in a study in Iran, diagnostic agreement was 80% between SCID-5 and Conner’s Adult ADHD Rating Scale-Self Report-Screening Version (CAARS-S-SV) [ 42 ].…”

Section: Methodsmentioning

confidence: 99%

Comorbidity of adult ADHD and substance use disorder in a sample of inpatients bipolar disorder in Iran

et al. 2022

View full text Add to dashboard Cite

Backgrounds The study of the relationship between adult Attention deficit hyperactivity disorder (ADHD) and bipolar disorder has received more attention in recent years and there is limited information in this area. On the other hand, there is a significant comorbidity between ADHD and bipolar disorder with substance use disorder. In this study, we investigated the prevalence of comorbidity of adult ADHD and substance use disorder among a group of bipolar patients admitted to a psychiatric hospital. Methods One hundred fifty patients from a total of 200 consecutive patients who were referred to the emergency department of Roozbeh Psychiatric Hospital in Tehran, diagnosed with bipolar disorder based on the initial psychiatric interview and needed hospitalization, were evaluated again by an experienced faculty member psychiatrist by using a subsequent interview based on the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition(DSM-5). They were evaluated using the Structured Clinical Interview for DSM-5 (SCID-5) questionnaire to confirm the diagnosis of bipolar disorder and the comorbidity of adult ADHD and substance use disorder. Results From 150 patients diagnosed with bipolar disorder, 106 patients (70.7%) had adult ADHD. 89 patients (59.3%) had substance use disorder and 58 patients (38.7%) had both of these comorbidities with bipolar disorder. Comorbidity of adult ADHD was associated with the earlier onset of the first mood episode in bipolar disorder (p value = 0.025). There was no statistically significant relationship between substance use disorder and age of onset of the first episode. (P value = 0.57). Conclusions Due to the limitations of studies on adult ADHD comorbidity with bipolar disorder, especially in hospital settings, as well as the increased risk of association with substance use disorder, further multicenter studies in this area with larger sample sizes can increase awareness in this regard.

show abstract

Section: Methodsmentioning

confidence: 99%

Comorbidity of adult ADHD and substance use disorder in a sample of inpatients bipolar disorder in Iran

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The diagnosis of ADHD was made according to DSM-5 criteria and confirmed using the Italian version of the semi-structured, clinician-administered Diagnostic Interview for ADHD in adults (DIVA 2.0) [ 24 ]. Whenever possible, a caregiver/family member of the patient participated in the interview to provide retrospective and collateral information.…”

Section: Methodsmentioning

confidence: 99%

“…The diagnosis of ADHD was made according to DSM-5 criteria and confirmed using the Italian version of the semi-structured, clinician-administered Diagnostic Interview for ADHD in adults (DIVA 2.0) [24]. Whenever possible, a caregiver/family member of the  BARRAT severity (total score)  BPRS severity (total score)  DERS severity (total score)  HSRS severity (total score)  WHODAS severity (total score)…”

Section: Instrumentsmentioning

confidence: 99%

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study

Pallucchini

Carli

Maremmani

et al. 2021

JCM

View full text Add to dashboard Cite

Attention-Deficit/Hyperactivity Disorder (ADHD) is the most widespread neurodevelopmental disorder, and it still persists into adulthood in 2–6% of the population. Psychiatric comorbidities are very common in adult ADHD (A-ADHD) patients; in particular, Substance Use Disorder (SUD) is found in 40% of these patients. Co-occurrence of ADHD and SUD is described as detrimental to clinical outcome by many authors, while only a few studies describe good clinical results in A-ADHD-SUD patients when they were treated for ADHD, both for the efficacy and the compliance of patients. In this study we tested to determine whether SUD can influence the treatment outcome of A-ADHD patients by correlating lifetime, past and current substance use in A-ADHD patients with their outcome (retention rate) during a 5-year follow-up of patients treated with stimulant and non-stimulant medications, using Kaplan–Meier survival analysis with overall and pairwise comparison. The association between demographic, symptomatological and clinical aspects with retention in treatment, adjusting for potential confounding factors, was summarized using Cox regression. After 5 years of observation, the cumulative treatment retention was 49.0%, 64.3% and 41.8% for A-ADHD patients without lifetime SUD (NSUD/A-ADHD), A-ADHD with past SUD (PSUD/A-ADHD) and A-ADHD with current SUD (CSUD/A-ADHD), respectively. Overall comparisons were not significant (Wilcoxon Rank-Sum (statistical) Test = 1.48; df = 2; p = 0.477). The lack of differences was confirmed by a Cox regression demonstrating that the ADHD diagnosis according to DIVA, gender, education, civil status, presence of psychiatric comorbidity, and psychiatric and ADHD familiarity; severity of symptomatological scales as evaluated by WHODAS, BPRS, BARRAT, DERS, HSRS, and ASRS did not influence treatment drop-out (χ2 22.30; df = 20 p = 0.324). Our A-ADHD-SUD patients have the same treatment retention rate as A-ADHD patients without SUD, so it seems that substance use comorbidity does not influence this clinical parameter.

show abstract

“…These comprehensive interviews include past and current symptom evaluation, differential diagnosis, complemented with documentation of examples of functional impairments. The Diagnostic Interview for ADHD (DIVA) ( (accessed on 30 July 2022)) has now been translated into 25 languages and has greatly facilitated clinician acceptance and comfort with diagnostic assessment for ADHD [ 32 , 33 , 34 , 35 ]. DIVA-5 asks about the presence of ADHD symptoms over time, as well as lifetime functional impairments due to these symptoms.…”

Section: Tools For Measurement Informed Assessmentmentioning

confidence: 99%

A Paradigm for Targeting Functional Impairment as an Outcome in Attention-Deficit/Hyperactivity Disorder

Weiss

2022

Brain Sciences

View full text Add to dashboard Cite

Although functional impairment is required for a diagnosis in the DSM 5, the time frame and definition of functional impairment is ambiguous. We present a conceptual review clarifying the difference between functional impairment as a stable trait representing strength or disability in various domains, and functional impairment as secondary to emotional or behavior problems, which is a state sensitive to change with treatment intervention. Functional impairment as a measure of treatment outcome includes both change from baseline and status at the endpoint of treatment. When using a validated measure of function, functional improvement can be defined as the percentage of patients who achieve the Minimal Important Clinical Difference (MCID) and functional remission as the percentage of patients who normalize at treatment endpoint. True treatment remission should be defined as both symptomatic and functional remission.

show abstract

Reliability, Criterion and Concurrent Validity of the Farsi Translation of DIVA-5: A Semi-Structured Diagnostic Interview for Adults With ADHD

Cited by 12 publications

References 24 publications

Comorbidity of adult ADHD and substance use disorder in a sample of inpatients bipolar disorder in Iran

Comorbidity of adult ADHD and substance use disorder in a sample of inpatients bipolar disorder in Iran

Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study

A Paradigm for Targeting Functional Impairment as an Outcome in Attention-Deficit/Hyperactivity Disorder

Contact Info

Product

Resources

About